Philips Q3 Profit Plunges, Adj. EBITDA Up; Backs FY26 Outlook
Philips reported Q3 net income of €28M, down from €187M last year, due to a Respironics DOJ settlement. Adjusted EBITDA rose to €772M, with sales up 2% to €4.39B. The company maintained its FY26 outlook, expecting 3-4.5% sales growth and adjusted EBITA margin of 13.5-14%.
How this was made
The 30-second read
Why it matters
The earnings miss may trigger short‑term price pressure, but the ongoing productivity program and modest guidance could limit the decline.
Market read
Philips' earnings miss is the primary market‑moving event; other companies are mentioned only for comparison.
What to watch
The 288M euro DOJ settlement provision is a one‑off charge; underlying sales growth remains solid.
Background
Philips is a Dutch consumer electronics and health‑technology company; its Q3 results were released on Nov 3 2026.
Ticker impact
Philips reported Q3 net income of €28M, a sharp decline from €187M a year earlier, and provided FY26 guidance.
likely downside as market prices in lower profit and modest outlook
The profit plunge and unchanged FY26 outlook suggest limited upside; investors may sell on the earnings disappointment.
Market effects
Healthcare equipment sector may see pressure as a major player reports weaker profit.
European markets could be mildly affected by Philips' results.
Limited; impact confined to Philips and its peers.
Counterpoint
The adjusted EBITDA beat and cost‑saving program could support a rebound if investors focus on operational improvements.
Key entities
- companyPhilips
Dutch consumer electronics and health‑technology giant reporting Q3 results.